BioCryst Pharmaceuticals Inc (BCRX) stock
BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$7.30−0.20 (-2.67%)
Close on Nov 18, 2026Market cap $1.87BP/E –Yield –
BioCryst Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BioCryst Pharmaceuticals's price to book ratio was 44.7× on Jan 29, 2021, against 15.5× a year earlier. Over the last 5 years it ranged from 3.1× to 392.8×, with a median of 13.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 44.7× | +5.6 |
| 2020 | Dec 31, 2020 | 39.1× | +23.6 |
| 2019 | Jul 31, 2019 | 15.5× | +3.4 |
| 2018 | Dec 31, 2018 | 12.1× | +7.3 |
| 2017 | Dec 29, 2017 | 4.8× | −112.1 |
| 2016 | Dec 30, 2016 | 116.9× | +105.1 |
| 2015 | Dec 31, 2015 | 11.8× | +1.3 |
| 2014 | Dec 31, 2014 | 10.5× | −121.2 |
| 2013 | Dec 31, 2013 | 131.7× | +124.3 |
| 2012 | Dec 31, 2012 | 7.4× | +7.4 |
| 2011 | Dec 30, 2011 | 0.0× | – |
See a number that looks wrong?